Please assess the completion status of the following clinical trial:

Trial Title: TRIGEN SURESHOT™ Distal Targeting System Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~* Unilateral femoral shaft fracture requiring intramedullary nailing in which the use of stereotactic surgery may be appropriate.~* Subject is between 18-80 years of age.~* Subject is skeletally mature~* Subject is of legal age and capable of providing legal consent.~* Subject is suitable for current Intramedullary Nailing procedure~* Subject willing to accept randomization either to the TRIGEN SURESHOT Distal Targeting System or TRIGEN standard instrumentation.~Exclusion Criteria~* Femur shaft fracture not amenable to intramedullary nailing in which the use of sterotactic surgery may be inappropriate.~* Fracture with vascular injury (Gustilo Type IIIC) requiring repair~* Open fractures where open wound is in communication with distal targeting holes and therefore would influence duration of locking procedure (i.e. potentially no need for incisions for locking screw placement).~* Fracture of the Metaphyseal distal femur with intraarticular comminution~* Known Pathological Fracture~* Subject is a prisoner~* Operative procedure for closed fracture is scheduled for greater than 2 weeks for closed fractures~* Subject has cognitive issue/mental status conditions that preclude intramedullary nailing in the judgment of the investigator.~* Contralateral femoral shaft fracture

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- TRIGEN SURESHOT Distal Targeting (Type: EXPERIMENTAL): TRIGEN SURESHOT Distal Targeting Instrumentation is utilized to find screw holes.
- Standard Nailing Instrumentation. (Type: ACTIVE_COMPARATOR): Free-hand technique utilizes x-rays to find screw holes

Based on this trial design, predict the completion outcome and termination type (if applicable).